These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 15470334

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Nitroflurbiprofen, a nitric oxide-releasing cyclooxygenase inhibitor, improves cirrhotic portal hypertension in rats.
    Laleman W, Van Landeghem L, Van der Elst I, Zeegers M, Fevery J, Nevens F.
    Gastroenterology; 2007 Feb; 132(2):709-19. PubMed ID: 17258737
    [Abstract] [Full Text] [Related]

  • 3. Gastric tolerability and prolonged prostaglandin inhibition in the brain with a nitric oxide-releasing flurbiprofen derivative, NCX-2216 [3-[4-(2-fluoro-alpha-methyl-[1,1'-biphenyl]-4-acetyloxy)-3-methoxyphenyl]-2-propenoic acid 4-nitrooxy butyl ester].
    Wallace JL, Muscará MN, de Nucci G, Zamuner S, Cirino G, del Soldato P, Ongini E.
    J Pharmacol Exp Ther; 2004 May; 309(2):626-33. PubMed ID: 14755007
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Nitric oxide-releasing flurbiprofen reduces formation of proinflammatory hydrogen sulfide in lipopolysaccharide-treated rat.
    Anuar F, Whiteman M, Siau JL, Kwong SE, Bhatia M, Moore PK.
    Br J Pharmacol; 2006 Apr; 147(8):966-74. PubMed ID: 16491094
    [Abstract] [Full Text] [Related]

  • 7. Protective effect of NO on gastric lesions and inhibition of expression of gastric inducible NOS by flurbiprofen and its nitro-derivative, nitroflurbiprofen.
    Mariotto S, Menegazzi M, Carcereri de Prati A, Cuzzolin L, Adami A, Suzuki H, Benoni G.
    Br J Pharmacol; 1995 Sep; 116(2):1713-4. PubMed ID: 8528547
    [Abstract] [Full Text] [Related]

  • 8. Healing of chronic gastric ulcers in diabetic rats treated with native aspirin, nitric oxide (NO)-derivative of aspirin and cyclooxygenase (COX)-2 inhibitor.
    Brzozowska I, Targosz A, Sliwowski Z, Kwiecien S, Drozdowicz D, Pajdo R, Konturek PC, Brzozowski T, Pawlik M, Konturek SJ, Pawlik WW, Hahn EG.
    J Physiol Pharmacol; 2004 Dec; 55(4):773-90. PubMed ID: 15613743
    [Abstract] [Full Text] [Related]

  • 9. Differential effects of the nonsteroidal antiinflammatory drug flurbiprofen and its nitric oxide-releasing derivative, nitroflurbiprofen, on prostaglandin E(2), interleukin-1beta, and nitric oxide synthesis by activated microglia.
    Ajmone-Cat MA, Nicolini A, Minghetti L.
    J Neurosci Res; 2001 Nov 15; 66(4):715-22. PubMed ID: 11746392
    [Abstract] [Full Text] [Related]

  • 10. The flurbiprofen derivatives HCT1026 and HCT1027 inhibit bone resorption by a mechanism independent of COX inhibition and nitric oxide production.
    Idris AI, Del Soldato P, Ralston SH, van't Hof RJ.
    Bone; 2004 Sep 15; 35(3):636-43. PubMed ID: 15336599
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Pharmacokinetics and pharmacodynamics of enantiomers of ibuprofen and flurbiprofen after oral administration.
    Suri A, Grundy BL, Derendorf H.
    Int J Clin Pharmacol Ther; 1997 Jan 15; 35(1):1-8. PubMed ID: 9021434
    [Abstract] [Full Text] [Related]

  • 13. Opposite effects of flurbiprofen and the nitroxybutyl ester of flurbiprofen on apoptosis in cultured guinea-pig gastric mucous cells.
    Johal K, Hanson PJ.
    Br J Pharmacol; 2000 Jun 15; 130(4):811-8. PubMed ID: 10864887
    [Abstract] [Full Text] [Related]

  • 14. Synthesis and biological activity of flurbiprofen analogues as selective inhibitors of beta-amyloid(1)(-)(42) secretion.
    Peretto I, Radaelli S, Parini C, Zandi M, Raveglia LF, Dondio G, Fontanella L, Misiano P, Bigogno C, Rizzi A, Riccardi B, Biscaioli M, Marchetti S, Puccini P, Catinella S, Rondelli I, Cenacchi V, Bolzoni PT, Caruso P, Villetti G, Facchinetti F, Del Giudice E, Moretto N, Imbimbo BP.
    J Med Chem; 2005 Sep 08; 48(18):5705-20. PubMed ID: 16134939
    [Abstract] [Full Text] [Related]

  • 15. Effect of a new non-steroidal anti-inflammatory drug, nitroflurbiprofen, on the expression of inducible nitric oxide synthase in rat neutrophils.
    Mariotto S, Cuzzolin L, Adami A, Del Soldato P, Suzuki H, Benoni G.
    Br J Pharmacol; 1995 May 08; 115(2):225-6. PubMed ID: 7545516
    [Abstract] [Full Text] [Related]

  • 16. Nitric oxide release and distribution following oral and intraperitoneal administration of nitroaspirin (NCX 4016) in the rat.
    Carini M, Aldini G, Orioli M, Piccoli A, Rossoni G, Maffei Facino R.
    Life Sci; 2004 May 14; 74(26):3291-305. PubMed ID: 15094329
    [Abstract] [Full Text] [Related]

  • 17. Nitroflurbiprofen NicOx SA.
    Wang X.
    IDrugs; 1998 Nov 14; 1(7):807-12. PubMed ID: 18465650
    [Abstract] [Full Text] [Related]

  • 18. In vitro and in vivo profiling of CHF5022 and CHF5074 Two beta-amyloid1-42 lowering agents.
    Imbimbo BP, Del Giudice E, Cenacchi V, Volta R, Villetti G, Facchinetti F, Riccardi B, Puccini P, Moretto N, Grassi F, Ottonello S, Leon A.
    Pharmacol Res; 2007 Apr 14; 55(4):318-28. PubMed ID: 17292621
    [Abstract] [Full Text] [Related]

  • 19. Effects of low-dose aspirin on gastric erosions, cyclooxygenase expression and mucosal prostaglandin-E2 do not depend on Helicobacter pylori infection.
    Venerito M, Treiber G, Wex T, Kuester D, Roessner A, Di Mario F, Malfertheiner P.
    Aliment Pharmacol Ther; 2006 Apr 15; 23(8):1225-33. PubMed ID: 16611284
    [Abstract] [Full Text] [Related]

  • 20. Nitroflurbiprofen, a new nonsteroidal anti-inflammatory, ameliorates structural injury in the remnant kidney.
    Fujihara CK, Malheiros DM, Donato JL, Poli A, De Nucci G, Zatz R.
    Am J Physiol; 1998 Mar 15; 274(3):F573-9. PubMed ID: 9530274
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.